Start Date
February 28, 2023
Primary Completion Date
April 30, 2023
Study Completion Date
May 31, 2023
NRPT
Subjects randomly assigned to the active group will receive Nicotinamide Riboside and Pterostilbene (each capsule contains 125 mg NR and 25 mg PT, total daily dose is 2 capsules) for 3 weeks
Placebo oral capsule
Subjects randomly assigned to the Placebo group will receive placebo oral capsules for 3 weeks
University of Exeter, Exeter
Lead Sponsor
University of Exeter
OTHER
Elysium Health
INDUSTRY